Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Immix Biopharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q4 2024
- Shares held
- 2.92M
- +47.5K (+1.7%) vs. Q4 2024
- Total value
- $4.90M
- −$1.41M (−22.4%) vs. Q4 2024
- New holders
- 3
- 4 more added
- Sold out
- 4
- 8 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bleichroeder LP | 850,000 | $1.43M | 0.38% | 00.0% | Unchanged |
| Cable Car Capital LLC | 779,358 | $1.31M | 1.49% | −16,742−2.1% | Reduced |
| Vanguard Group Inc | 698,537 | $1.17M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 160,742 | $270.1K | 0.00% | +10,660+7.1% | Added |
| Northern Trust Corp | 95,262 | $160.0K | 0.00% | +56,348+144.8% | Added |
| Morgan Stanley | 82,292 | $138.3K | 0.00% | −8,759−9.6% | Reduced |
| Susquehanna International Group, LLP | 55,262 | $92.8K | 0.00% | +55,262 | New |
| State Street Corp | 42,960 | $72.2K | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 31,225 | $52.5K | 0.00% | 00.0% | Unchanged |
| Tocqueville Asset Management L.P. | 29,300 | $49.2K | 0.00% | −9,000−23.5% | Reduced |
| SBI Securities Co., Ltd. | 17,500 | $29.4K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 17,040 | $29.0K | 0.00% | −8,820−34.1% | Reduced |
| XTX Topco Ltd | 12,833 | $21.6K | 0.00% | +12,833 | New |
| Colony Group, LLC | 11,900 | $20.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 11,824 | $19.9K | 0.00% | −2,252−16.0% | Reduced |
| FNY Investment Advisers, LLC | 11,250 | $18.0K | 0.01% | −17,500−60.9% | Reduced |
| UBS Group AG | 10,121 | $17.0K | 0.00% | −4,087−28.8% | Reduced |
| Tower Research Capital LLC (TRC) | 471 | $791 | 0.00% | +290+160.2% | Added |
| Wells Fargo & Company | 330 | $554 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 120 | $202 | 0.00% | +6+5.3% | Added |
| Northwestern Mutual Wealth Management Co | 80 | $134 | 0.00% | +80 | New |
| JPMorgan Chase & Co | 35 | $59 | 0.00% | −3−7.9% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,523−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |